February 2016 | News | Trends

Trends—February 2016

Tags: Rail, Pharmaceutical Logistics, Transportation, Logistics, Supply Chain

UAV Operators Wait As FAA Guidelines Drone On

Amazon CEO Jeff Bezos announced in 2013 that Amazon Prime Air would use unmanned drones to deliver packages to your door in 30 minutes or less. The online retailer has since claimed that it is only waiting for the government to make drone package delivery legal.

Unfortunately, the Federal Aviation Administration (FAA) regulations that would make commercial unmanned aerial vehicles (UAVs) legal are still in the revision process.

Several concessions will need to be made to allow for commercial use. For example, unless provisions are added to allow UAVs to fly out of their pilots' line of sight, Amazon's testing, research, and development will likely remain overseas. Additionally, current rules prohibit drones from flying at night, and operators are allowed to fly only one drone at a time.

Google, however, has had some recent drone success. In 2014, the company filed for a patent for Project Wing, a drone delivery model that uses a mobile delivery receptacle on the ground (which appears to be a box with wheels) to receive packages from drones. The drone delivers the package into the ground vehicle, which then returns to a secure location where it is either delivered to its final destination by a carrier or picked up by the customer. The patent was approved in January 2016.

When Google announced Project Wing, it hoped to implement the service by 2017. Dave Vos, the project's leader, thinks that's still a possibility. "Look up into the sky in 2017 and you could see drone deliveries happening on a regular basis," Vos said at an Aero Club aviation event in January 2016.

FAA revisions to existing rules are expected sometime in 2016. If those revisions allow for commercial drones to operate in the United States, Vos's dream might become reality. But the FAA is taking its time because previous projections revealed it was likely that more than 7,000 companies would obtain licenses to operate drone fleets once commercial UAVs became legal.

Google has already done most of the legwork for Project Wing; it began testing the drones in Australia in 2014. Amazon has also done testing overseas, so it's likely that Prime Air would also be ready to go once the FAA gives the green light. And it's not just retailers. Parcel carrier DHL has been testing drones in Germany since 2013.

"I advocate strongly that the need for additional regulation is small," Vos said during a speech at a Consumer Electronics Conference in Las Vegas. "In fact, if you allow people to replicate what manned aviation pilots in this airspace do, it already works.

"We don't need new regulation; we need to just be allowed to go do it," he added.

With customers now demanding that companies not only deliver free, but fast, it seems like drones are all but inevitable. Let's see if the FAA agrees.

Pharma Supply Chains Injecting a Dose of Innovation

The pharmaceutical supply chain has always been complex, and 2016 will be no different. Here are the top five challenges pharma manufacturers and logistics providers will face in the coming year, according to The Challenges, Solutions, and Strategies Driving Pharmaceutical Supply Chain Innovation, a cooperative whitepaper from research partners Kenco and LogiPharma.

  1. Item-level serialization. With counterfeit products flooding the market, serialization is becoming necessary for most pharma manufacturers. Serialization provides the ability to identify products at the item level through RFID or other means. Then, in the event of a problem, the manufacturer can pinpoint exactly which product needs to be recalled, reducing costs associated with a massive recall. Many companies have decided the benefits of this technology outweigh the costs, and are investing accordingly.
  2. Product diversification. As long as there is disease, injury, and illness, the pharma industry will release new products to combat them. Mergers and acquisitions, multiple manufacturing locations, and regulatory problems are all obstacles that make it difficult to effectively segment pharma supply chains to operate most efficiently.
  3. Regulations and compliance. Pharma and biotech companies struggle to find ways to improve their supply chains without accidentally violating one of the many regulations that govern their products. Different regulations covering each product create a lot of red tape to track.
  4. Big data. Because of the industry's complexity, many pharma supply chain stakeholders have yet to successfully turn the data they gather into real improvements.
  5. Emerging markets. Big pharma sees potential in global markets, but currently lacks the global supply chain to successfully engage these areas. Companies will make massive investments in 2016 to remedy this.

Supply chain executives in the pharma industry need to be able to make changes based on demand fluctuations, and respond quickly to any potential disruption. To do that, they need as much end-to-end supply chain visibility as they can get. A 2015 LogiPharma survey reveals that gaining visibility is the largest concern among pharma executives for 2016 (see chart, left).

Many companies find the answer in enterprise resource planning (ERP) systems. Traditionally a tool of large enterprises, small pharma businesses are beginning to see the benefits of an ERP system. While 21 percent of respondents aren't currently using an ERP, half of this group are actively working to install one, according to the survey.

In addition to ERP systems, 78 percent of pharmaceutical company respondents say they will use third-party vendors and partners in 2016 to increase visibility and meet other challenges. In addition, 66 percent already use third-party partners in their fulfillment and distribution operations, while 67 percent use a third-party partner to manage transportation.

The pharma industry has spoken: Supply chain optimization is the cure for what ails you.

2016’s Top Pharma Concerns

A transparent supply chain enables the visibility that allows planners to diagnose potential disruptions early and make changes based on demand.

Source: LogiPharma Pharmaceutical Supply Chain Innovation Report

E-commerce Sales Now More Important Than Stores

Retailers, distributors, suppliers, and logistics firms remain optimistic despite the challenges they face as they tackle growing customer expectations, according to SPS Commerce's fourth annual Retail Insight industry benchmark report. Two key trends emerge from the report: E-commerce and stores have switched places as the top growth driver; and suppliers are not keeping up with the omni-channel retail demands of digital consumers and their retail customers.

The Retail Insight benchmark study, which surveys members of the SPS Retail Network, reveals the following:

  • Retailers rank growing e-commerce sales as their top priority (75 percent), followed by improving the in-store experience (53 percent).
  • Distributors (80 percent) and logistics service providers (41 percent) are focused on rapid fulfillment above all else.
  • Suppliers (80 percent) place streamlined fulfillment as their top priority, yet 45 percent lag in omni-channel strategy and execution, with only 18 percent claiming even moderate success.
  • Retailers cite more or improved item attributes as their top desire from vendors in 2016 (69 percent), while distributors need vendors to provide visibility to available inventory (75 percent).
  • Legacy systems (59 percent) and cultures adverse to change (38 percent) are key inhibitors to retailers' omni-channel progress.
  • Retailers rate their visibility to available inventory from supplier warehouses as critically low (21 percent) and in-store visibility at insufficient levels (75 percent) to meet consumer demand.

"For the first time in four years, we see retailers pursuing suppliers that can provide critical omni-channel capabilities of rapid fulfillment, rich item and inventory information, and drop-ship capabilities to fuel growth plans," says Peter Zaballos, vice president of marketing and product at SPS Commerce.

Putting the STB Back on Track

Over the past few years, things have gone off the rails in the United States. Since the shale oil boom began affecting markets and transportation in 2008, Class I railroads have increasingly given oil cargo preference over agricultural freight, causing significant delays for the perishable cargo and substantial injury to farmers' pocketbooks.

The Surface Transportation Board (STB) Reauthorization Act was passed by Congress and signed into law by President Obama to remove obstacles that stop the federal oversight organization responsible for the U.S. freight rail system from intervening. This new overhaul increases the agency's ability to investigate disputes, sets timelines for rate reviews, and increases the size of the board from three members to five to streamline decision-making.

"Enacting this legislation will make the Surface Transportation Board more accountable and effective in addressing rail service and other disputes," says Senator John Thune, who sponsored the bill in the Senate. "Heading off problems between rail customers and carriers whenever possible, and quickly resolving them when they do occur, is at the heart of this effort to make the STB work better."

The American Association of Railroads (AAR) also voiced approval of the measure. "It strikes the balance of preserving market-based structures for shippers and railroads while also providing common sense process improvements to help the board work more efficiently," says Ed Greenberg, spokesman for the AAR.

"Hopefully it will put the board in the position where it could be more effective in responding to both the railroads and the shipper community," Thune adds.

As the United States becomes less dependent on foreign oil, and the Keystone XL pipeline project remains in mothballs, more oil will continue to flow down U.S. railroad tracks. Agricultural stakeholders hope that the STB changes are a step toward keeping all cargo moving effectively, and not just oil.